Bedfont’s long-standing UK distributor, Intermedical UK, will be exhibiting their breath analysis medical products at the annual ARTP conference.
A distributor for nearly 10 years, Intermedical UK will be exhibiting the 2nd generation NObreath at the annual Association for Respiratory Technology & Physiology (ARTP) conference and can be found at Stand 25.
FeNO monitoring with the NObreath offers a quick, simple and non-invasive method of assessing airway inflammation for aiding the diagnosis and management of asthma. Interpreting FeNO levels aids in identifying patients who do/do not require on-going treatment(1) whilst also differentiating between allergic (eosinophilic) and non-allergic asthma(2), and if used daily, FeNO measurements can help to predict exacerbations and attacks(3).
New features for the NObreath includes the ability to save patient profiles on the device, Bluetooth connectivity, and SteriTouch technology for optimum infection control. The 2nd generation model also has a fresh and aesthetically pleasing design with a full-colour touchscreen. Furthermore, the NObreath comes with free patient management software allowing the equipment to synchronise with a PC, enabling reports to be generated, data to be backed up, and much more.
Livio Gagliardi, Acting Managing Director at Intermedical, said, “We’re excited to bring the NObreath to ARTP this year. It’s a great opportunity to talk about the benefits of measuring FeNO when monitoring asthma and airway inflammation – especially now it is recommended in the NICE guidance. We believe that the new NObreath will make FeNO monitoring quicker and easier for healthcare professionals and patients alike.”
This year, ARTP is taking place between 31 January and 1st February in Glasgow.